0

ABH Antigenicity of in Situ Carcinoma of the Urinary Bladder During Intracavity Treatment With Doxorubicin Hydrochloride

G Jakse, F Hofstädter

Urol Res. 1981;9(3):153-6.

PMID: 7257030

Abstract:

Ten patients with carcinoma in situ of the urinary bladder were treated topically with doxorubicin hydrochloride. Blood group antigens were evaluated by the specific red cell adherence tests. Carcinoma in situ was associated with the loss of antigenicity, the reappearance of which could be demonstrated in patients with tumour remission. This occurred in spite of a persistent nuclear atypia.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP194656752 ABH hydrochloride ABH hydrochloride 194656-75-2 Price
qrcode